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Abstract Structural properties and conformational stability of
de novo proteins ^ albebetin and albeferon (albebetin with a
grafted interferon fragment) ^ were studied by means of CD
spectroscopy, gel filtration and urea-induced unfolding. The
results allow us to conclude that albebetin possesses the
properties of the molten globule state. Grafting of the octapep-
tide to the N-terminus of this de novo protein affects its structure.
We show here that albeferon maintains a secondary structure
content of albebetin; it becomes more compact and much more
stable toward urea-induced unfolding as compared to albebetin
and even possesses some weak tertiary structure (at least around
Tyr7). This means that the structure of the artificial protein
albebetin can be improved by a simple procedure of octapeptide
grafting to its N-terminus.
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1. Introduction
The de novo design and production of proteins which en-
sures a desirable three-dimensional structure and function is
one of the most intriguing challenges of modern protein en-
gineering, and the best way to test our understanding of the
principles of protein structure and folding. The ¢rst successful
engineering of a de novo protein ^ a four-helix bundle ^ was
reported 10 years ago [1]. During the last few years a number
of attempts have been made in this direction [2,3]. Most of the
designed structures mimicked the structures of natural pro-
teins.
In 1991 the de novo protein albebetin was constructed [4^
6]. This protein was designed to form a tertiary fold ^ a four-
stranded antiparallel L-sheet with one side screened by two K-
helices ^ which does not contradict any structural rules, but
has never been observed in natural proteins. Analysis of its
structure by gel ¢ltration, urea gradient electrophoresis and
limited proteolysis showed compactness and relative stability
of this protein [5,6].
The next attractive step in the ¢eld of de novo protein
engineering is the construction of a protein with pre-designed
structure and some kind of biological activity. We have
grafted an eight amino acid fragment (131^138) of human
interferon K2 (carrying the blast transforming activity of this
protein) to albebetin [7,8]. The gene of a chimerical protein
was expressed in a wheat cell-free system and the synthesized
protein (albeferon) was tested using the approach elaborated
for the fast testing of structural properties of de novo proteins
at the nanogram level [5,6]. We have shown that albebetin
with the grafted octapeptide is practically as compact as nat-
ural proteins of corresponding molecular weight and possesses
high stability toward urea-induced unfolding [7,8]. Addition-
ally, it was shown that albeferon binds murine thymocyte
receptor with high a⁄nity and e⁄ciently activates the thymo-
cyte blast transformation [7,8]. It is important to emphasize
here that the previous studies of albebetin and albeferon were
performed on radiolabeled proteins obtained in a cell-free
system. We believe that this approach ^ ¢rst to test protein
obtained in a cell-free system and then to express it in Esche-
richia coli in preparative amounts for detailed analysis ^ can
be a general one for the investigation of de novo and mutant
proteins.
In the present paper we describe the expression of genes
encoding two de novo proteins (albebetin and albeferon) in
E. coli and investigations of these proteins. We show that
albebetin has a pronounced secondary structure and a high
degree of compactness. At the same time grafting of the in-
terferon octapeptide to this protein changes its structural
properties. Our data are consistent with the suggestion that
the secondary structure content of albeferon is close to that of
albebetin, but the modi¢ed protein is more compact and sub-
stantially more stable toward urea-induced unfolding. It al-
lows us to conclude that grafting the interferon fragment to
albebetin can improve the structure of this de novo protein.
2. Materials and methods
2.1. Materials
T4 DNA ligase, VentR polymerase, factor Xa protease and other
enzymes and chemicals were from New England Biolabs (USA), Phar-
macia (Sweden), Sigma (USA), Serva (USA), Bio-Rad (USA), and
Amersham (UK).
2.2. Cloning and expression of albeferon
Standard methods were used for genetic engineering procedures
such as DNA digestion and analysis with restriction endonucleases,
ligation and transformation of E. coli, preparation and puri¢cation of
DNA fragments, etc.
The albebetin and albeferon genes were expressed in E. coli in a
fusion expression system with maltose binding protein purchased from
New England Biolabs (NEB). The genes were cloned into plasmid
pMALc following the N-terminal part of the maltose binding protein
gene. Expression, puri¢cation, cleavage of the fusion proteins with
factor Xa protease as well as the ¢nal a⁄nity chromatography puri-
¢cation of de novo proteins on amylose binding resin were performed
according to the NEB manual as described elsewhere [9]. The proteins
were monitored by SDS-polyacrylamide gel electrophoresis at 10% gel
according to Laemmli [10] as well as at 12.5% gel in Tris-tricine bu¡er
system [11,12].
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2.3. Spectral measurements
Circular dichroism (CD) studies were carried out with Jasco-600
and Jasco-41A spectropolarimeters (Japan Spectroscopic Co., Ltd,
Tokyo, Japan). Both instruments were equipped with a temperature-
controlled holder. Protein concentration was 1.7 and 0.88 mg/ml for
near and far UV CD measurements, respectively. Cell pathlength was
0.148 and 10 mm for far and near UV CD measurements, respec-
tively. To investigate the temperature dependence of the spectra, a
scanning rate of 0.9‡C/min was used.
3. Results
3.1. Tertiary structure (near UV CD spectra)
Fig. 1 represents near UV CD spectra of two de novo
proteins, albebetin (solid line) and albeferon (dashed line).
One can see there are no speci¢c signals in the near UV CD
spectrum of albebetin which is quite natural since this protein
has no tryptophan and tyrosine residues. As for albeferon,
this protein gets a tyrosine residue in position 7 (Tyr7) from
the grafted interferon fragment. The chirality of the Tyr7 en-
vironment may be responsible for the appearance of speci¢c
bands in the near UV CD spectrum of this protein (e.g. mini-
ma at 265 and 276 nm, see curve 2 in Fig. 1). On the other
hand, Fig. 1 shows that the overall intensity of the near UV
CD spectrum of this protein is relatively low. This observation
allows us to conclude that albeferon has some tertiary struc-
ture (at least, in the environment of Tyr7).
3.2. Secondary structure (far UV CD spectra)
Far UV CD spectra of albebetin and albeferon are shown
in Fig. 2 as solid and dashed lines, respectively. As follows
from Fig. 2, both de novo proteins have similar far UV CD
spectra at the conditions studied (100 mM potassium phos-
phate bu¡er pH 8.0, 25‡C). The quantitative analysis of these
spectra according to Provencher and Gloºckner [13] showed
that albebetin contains 29% K- and 40% L-structure, while
albeferon has 27% K- and 35% L-structure. These values are
close to the pre-designed ones (30% K- and 36% L-structure),
suggesting that the secondary structure design of the proteins
was successful.
3.3. Compactness (gel ¢ltration)
Compactness of the de novo proteins at various experimen-
tal conditions was studied by means of high performance
liquid chromatography. This approach makes it possible to
estimate the hydrodynamic dimensions of protein conformers
[14^18] with high accuracy at low concentrations. A summary
of the obtained results [6^8] is shown in Table 1. The table
presents the hydrodynamic dimensions of albebetin and albe-
feron in comparison with those of native and unfolded glob-
ular proteins of corresponding molecular weights estimated
according to empirical equations [16] based on the intrinsic
viscosity data [19]:
log RNS  0:369 logM30:254 1
and
log RUS  0:533 logM30:682 2
where RNS and R
U
S are Stokes radii of the native (N) and
unfolded (U) protein, respectively, while M is the protein
molecular weight (in Da). Table 1 shows that in the absence
of denaturant the RS value of albeferon is somewhat smaller
than that of albebetin. This di¡erence is consistent with the
situation when the grafted octapeptide is attracted to albebe-
tin since in the opposite case one can expect some increase in
RS value rather than a decrease. On the other hand, the RS
value for albeferon in the absence of denaturant exactly co-
incides with that of natural native protein of the same molec-
ular weight. Thus Table 1 suggests that albeferon is as com-
pact as native natural globular protein of the same molecular
weight, whereas RS of albebetin exceeds the corresponding
values by a factor 1.13, which is the usual case for molten
globules [16,17,20].
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Fig. 1. Circular dichroism spectra of albebetin (solid line) and albe-
feron (dotted line) in the near UV region. Measurements were car-
ried out in 100 mM potassium phosphate bu¡er, pH 8.0 at 25‡C.
Protein concentration was 1.7 mg/ml. Cell pathlength was 10 mm.
Table 1
Hydrodynamic dimensions of albebetin and albeferon in di¡erent conformational states
Protein Conditions RS (Aî ) RS/RNS
Albebetin 0 M urea 17.2 þ 0.5 1.13
9 M urea 24.1 þ 0.8 1.59
Natural protein of the same M (7760 Da)a 0 M urea 15.2 1.00
8 M urea 24.6 1.62
Albeferon 0 M urea 16.0 þ 0.5 1.01
9 M urea 25.3 þ 0.8 1.59
Natural protein of the same M (8640)a 0 M urea 15.9 1.00
8 M urea 25.9 1.63
aStokes radius values in the native and completely unfolded states were calculated in accordance with Eqs. 1 and 2 (see text).
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3.4. Stability (urea-induced unfolding)
To obtain an idea of the conformational stability of di¡er-
ent proteins analysis of their stability toward denaturant-in-
duced unfolding is commonly used. Assuming an all-or-none
mechanism of the transition between the initial (native) and
¢nal (unfolded) states, it is possible to estimate the free energy
of the initial state relative to that of the unfolded one, vGfold,
under the given conditions as [19] :
vGfold  3RT ln Keq 3
where Keq is the equilibrium constant of the transition. It is
known that within the transition region, where it can be meas-
ured, the value of vGfold varies linearly with the denaturant
concentration [21] :
vGfold  vGH2Ofold m denaturant 4
The parameter m re£ects the dependence of the free energy on
the denaturant concentration, [denaturant] ; typically the value
of m is V1 kcal/mol for urea-induced unfolding of native
natural proteins [22]. The values of vGfold are usually extrapo-
lated linearly to determine its value in the absence of denatur-
ant, vGH2Ofold ; typical values of this parameter for the native
natural proteins are between 35 and 310 kcal/mol [22].
A detailed description of the urea-induced unfolding of al-
bebetin and albeferon was presented in our previous publica-
tions [6^8]. Although the all-or-none character of the urea-
induced unfolding was established only for albeferon [7,8],
and although unfolding transitions for these de novo proteins
were obtained by di¡erent methods (urea-gradient electropho-
resis for albebetin [6] and gel-permeation chromatography for
albeferon [7,8]), we assume that it is possible to use these data
for the analysis suggested. Results of this analysis are sum-
marized in Table 2, which also contains the urea concentra-
tions corresponding to the middles of corresponding unfold-
ing transitions ([urea]1=2 values) and the averaged values of
parameters m and vGH2Ofold estimated for urea-induced unfold-
ing of native natural proteins [22]. As follows from Table 2,
albebetin and albeferon, being relatively stable toward urea-
induced unfolding ([urea]1=2s 4.5 M), show considerable dif-
ferences in unfolding behavior. Table 2 shows that all param-
eters of the unfolding of albebetin ([urea]1=2, m, vG
H2O
fold ) are
substantially lower than those of albeferon. This means that
the grafting of an octapeptide to albebetin results in a consid-
erable stabilization of this de novo protein.
4. Discussion
The most important ¢nding of our work is that grafting the
octapeptide changes the structure of albebetin. Indeed, albe-
feron is a bit more compact than the non-modi¢ed protein
(RS = 16.0 þ 0.5 Aî , as compared with RS = 17.2 þ 0.5 Aî ) and
possesses cooperativity toward urea-induced unfolding almost
as high as that of natural protein of this molecular weight (see
Table 2). It was also shown that this modi¢ed protein has a
pronounced secondary structure (see Fig. 2). The near UV CD
spectrum of albeferon (Fig. 1) suggests that this de novo pro-
tein has some tertiary structure. On the other hand, it is nec-
essary to emphasize here that microcalorimetric studies
showed that neither albebetin nor albeferon has the rigid co-
operatively melted tertiary structure characteristic of native
natural proteins [9]. This means that either the tertiary struc-
ture of albeferon is too weak to be accompanied by any co-
operative heat absorption upon disruption or it is situated
only in the near environment of Tyr7 and does not touch
the rest of the molecule. This might be the reason for the
relatively low intensity of the near UV CD spectrum of albe-
feron as compared with native natural proteins.
It seems that our data make it possible to conclude that
engineering of speci¢c fragments and grafting them to the N-
and/or C-terminus of de novo proteins is a possible way to
improve their design. It has already been mentioned that the
current state of the art in the engineering of arti¢cial proteins
makes it possible to design successfully only more or less
ordered molten globules [23^26]. This means that an impor-
tant piece of knowledge in this area is still missing. The ap-
proach which we have used to design the chimerical albebetin
(attachment of the peptide to the terminus of de novo protein)
can be considered one more step toward the creation of arti-
¢cial proteins with a native-like unique structure.
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Table 2
Parameters of urea-induced unfolding of albebetin and albeferon
Protein vGH2Ofold (kcal/mol) m (kcal/mol [urea]1=2 (M)
Albebetin 32.9 þ 0.3 0.56 þ 0.07 4.6
Albeferon 35.2 þ 0.3 0.99 þ 0.07 5.6
Natural native protein 310635 V1 ^
Fig. 2. Circular dichroism spectra of albebetin (solid line) and albe-
feron (dotted line) in the far UV region. Measurements were carried
out in 100 mM potassium phosphate bu¡er, pH 8.0 at 25‡C. Pro-
tein concentration was 0.88 mg/ml. Cell pathlength was 0.148 mm.
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